ACTMAP
Actin maturation protease
Also known as: ACTMP_HUMAN, C19orf54, FLJ41131
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5BKX5
- Gene
- ACTMAP
- Ensembl
- ENSG00000188493
- Chromosome
- 19
- Canonical length
- 351 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Intermediate filaments,Centriolar satellite
OverviewNCBI Gene
Enables cysteine-type aminopeptidase activity and initiator methionyl aminopeptidase activity. Involved in protein processing. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
351 residues, UniProt reviewed canonical sequence.
>Q5BKX5|ACTMAP
1 MTSPCSPPLK PPISPPKTPV PQASSIPSPP LPPSPLDFSA LPSPPWSQQT PVPPPLPLPP
61 PPAATGPAPR HVFGLEKSQL LKEAFDKAGP VPKGREDVKR LLKLHKDRFR GDLRWILFCA
121 DLPSLIQEGP QCGLVALWMA GTLLSPPSGV PLERLIRVAT ERGYTAQGEM FSVADMGRLA
181 QEVLGCQAKL LSGGLGGPNR DLVLQHLVTG HPLLIPYDED FNHEPCQRKG HKAHWAVSAG
241 VLLGVRAVPS LGYTEDPELP GLFHPVLGTP CQPPSLPEEG SPGAVYLLSK QGKSWHYQLW
301 DYDQVRESNL QLTDFSPSRA TDGRVYVVPV GGVRAGLCGQ ALLLTPQDCS HLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACTMAP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- liver: 15 nTPM
- skeletal muscle: 14 nTPM
- small intestine: 10 nTPM
- duodenum: 9.9 nTPM
- tongue: 9.6 nTPM
- adrenal gland: 9.5 nTPM
Single-cell type
- epicardial cells: 114 nCPM
- cardiomyocytes: 80 nCPM
- adipocytes: 33 nCPM
- early primary spermatocytes: 27 nCPM
- epididymal basal cells: 25 nCPM
- medullary thymic epithelial cells: 24 nCPM
Immune cell
- myeloid DC: 5.7 nTPM
- non-classical monocyte: 5.1 nTPM
- classical monocyte: 4.5 nTPM
- intermediate monocyte: 3.7 nTPM
- plasmacytoid DC: 3.5 nTPM
- T-reg: 1.9 nTPM
Brain region
- medulla oblongata: 13 nTPM
- white matter: 13 nTPM
- pons: 12 nTPM
- basal ganglia: 11 nTPM
- cerebellum: 11 nTPM
- midbrain: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.2
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Actin maturation protease
- Actin maturation protease-like, C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ACTMAP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACTMAP as an antibody target. Whether an autoantibody or antibody against ACTMAP could matter depends on whether native ACTMAP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACTMAP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACTMAP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...